Mometasone Inteli

Medicinal product

(Invented) name

Mometasone Inteli

Active substance (s)

Mometazono furoatas

Strength

50 µg/dozėje

Pharmaceutical form

nosies purškalas (suspensija)

Route (s) of administration

vartoti į nosį

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R01AD09, Mometasone

Marketing authorisation holder

UAB Inteli Generics Nord, Lietuva

Date of authorisation

2018-03-29

Date of renewal

2023-03-22

Documents

4209 Mometasone Inteli II priedas 2023 06 05.docx

4209_pakuotes lapelis_2023-03-22.doc

Mometasone_Inteli_viešas AR.pdf

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Išpurškiamoje dozėje (0,1 ml) yra	1 dozėje
Mometazono furoatas	50 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
99176	85282	1085282	buteliukas	140 dozių ir dozavimo pompa N1		Receptinis	LT/1/18/4209/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2023-03-22	Perregistruotas
2018-03-29	Registruotas